These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38178851)
1. Topical delivery of extracted curcumin as curcumin loaded spanlastics anti-aging gel: Optimization using experimental design and ex-vivo evaluation. El Hosary R; Teaima MH; El-Nabarawi M; Yousry Y; Eltahan M; Bakr A; Aboelela H; Abdelmonem R; Nassif RM Saudi Pharm J; 2024 Jan; 32(1):101912. PubMed ID: 38178851 [TBL] [Abstract][Full Text] [Related]
2. Topical Delivery of Fenoprofen Calcium via Elastic Nano-vesicular Spanlastics: Optimization Using Experimental Design and In Vivo Evaluation. Farghaly DA; Aboelwafa AA; Hamza MY; Mohamed MI AAPS PharmSciTech; 2017 Nov; 18(8):2898-2909. PubMed ID: 28429293 [TBL] [Abstract][Full Text] [Related]
3. Novel Luliconazole Spanlastic Nanocarriers: Development and Characterisation. Marques SM; Chavan DU; Bhide PJ; Joshi M; Kumar L; Shirodkar RK Curr Drug Deliv; 2023; 20(6):792-806. PubMed ID: 35578877 [TBL] [Abstract][Full Text] [Related]
4. Formulation of Nanospanlastics as a Promising Approach for Improving the Topical Delivery of a Natural Leukotriene Inhibitor (3-Acetyl-11-Keto-β-Boswellic Acid): Statistical Optimization, in vitro Characterization, and ex vivo Permeation Study. Badria F; Mazyed E Drug Des Devel Ther; 2020; 14():3697-3721. PubMed ID: 32982176 [TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of surfactant-based elastic vesicular system for transdermal delivery of Cilostazole: Nemr AA; El-Mahrouk GM; Badie HA J Liposome Res; 2022 Jun; 32(2):159-171. PubMed ID: 33970754 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of Transdermal Delivery of Haloperidol via Spanlastic Dispersions: Entrapment Efficiency vs. Particle Size. Fahmy AM; El-Setouhy DA; Habib BA; Tayel SA AAPS PharmSciTech; 2019 Jan; 20(3):95. PubMed ID: 30694404 [TBL] [Abstract][Full Text] [Related]
7. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation. Elsherif NI; Shamma RN; Abdelbary G AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036 [TBL] [Abstract][Full Text] [Related]
8. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, Abdelmonem R; Al-Samadi IEI; El Nashar RM; Jasti BR; El-Nabarawi MA Drug Deliv; 2022 Dec; 29(1):2868-2882. PubMed ID: 36065090 [TBL] [Abstract][Full Text] [Related]
9. "Spanlastic nanovesicles for enhanced ocular delivery of vanillic acid: design, in vitro characterization, and in vivo anti-inflammatory evaluation". Ibrahim SS; Abd-Allah H Int J Pharm; 2022 Sep; 625():122068. PubMed ID: 35926753 [TBL] [Abstract][Full Text] [Related]
10. Spanlastic-laden in situ gel as a promising approach for ocular delivery of Levofloxacin: In-vitro characterization, microbiological assessment, corneal permeability and in-vivo study. Agha OA; Girgis GNS; El-Sokkary MMA; Soliman OAE Int J Pharm X; 2023 Dec; 6():100201. PubMed ID: 37560488 [TBL] [Abstract][Full Text] [Related]
11. Spanlastic-laden nanogel as a plausible platform for dermal delivery of bimatoprost with superior cutaneous deposition and hair regrowth efficiency in androgenic alopecia. Almutairy BK; Khafagy ES; Aldawsari MF; Alshetaili A; Alotaibi HF; Lila ASA Int J Pharm X; 2024 Jun; 7():100240. PubMed ID: 38577618 [TBL] [Abstract][Full Text] [Related]
12. Optimization of topical curcumin spanlastics for melanoma treatment. Ismail S; Garhy D; Ibrahim HK Pharm Dev Technol; 2023 Jun; 28(5):425-439. PubMed ID: 37078715 [TBL] [Abstract][Full Text] [Related]
13. Topical delivery of l-ascorbic acid spanlastics for stability enhancement and treatment of UVB induced damaged skin. Elhabak M; Ibrahim S; Abouelatta SM Drug Deliv; 2021 Dec; 28(1):445-453. PubMed ID: 33620008 [TBL] [Abstract][Full Text] [Related]
14. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies. Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628 [TBL] [Abstract][Full Text] [Related]
15. Formulation-by-Design of Efinaconazole Spanlastic Nanovesicles for Transungual Delivery Using Statistical Risk Management and Multivariate Analytical Techniques. Almuqbil RM; Sreeharsha N; Nair AB Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890316 [TBL] [Abstract][Full Text] [Related]
16. Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicular spanlastic dispersions: development, characterization and pharmacokinetic assessments. Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH Int J Pharm; 2015 Apr; 483(1-2):77-88. PubMed ID: 25666025 [TBL] [Abstract][Full Text] [Related]
17. Formulation, optimization and evaluation of ocular gel containing nebivolol Hcl-loaded ultradeformable spanlastics nanovesicles: In vitro and in vivo studies. Yasser M; El Naggar EE; Elfar N; Teaima MH; El-Nabarawi MA; Elhabal SF Int J Pharm X; 2024 Jun; 7():100228. PubMed ID: 38317829 [TBL] [Abstract][Full Text] [Related]
18. Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model. Mao KL; Fan ZL; Yuan JD; Chen PP; Yang JJ; Xu J; ZhuGe DL; Jin BH; Zhu QY; Shen BX; Sohawon Y; Zhao YZ; Xu HL Colloids Surf B Biointerfaces; 2017 Dec; 160():704-714. PubMed ID: 29035818 [TBL] [Abstract][Full Text] [Related]
19. Curcumin Loaded Ethosomal Gel for Improved Topical Delivery: Formulation, Characterization and Kumar B; Sahoo PK; Manchanda S Pharm Nanotechnol; 2021; 9(4):281-287. PubMed ID: 33563166 [TBL] [Abstract][Full Text] [Related]
20. Development of stable tocopherol succinate-loaded ethosomes to enhance transdermal permeation: In vitro and in vivo characterizations. Akhtar N; Akhtar N J Cosmet Dermatol; 2022 Oct; 21(10):4942-4955. PubMed ID: 35274433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]